EDGAR·FLOW

KIMBERLY CLARK CORP — Form 8-K

Filed November 5, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 72/100
What the filing says
On November 2, 2026, Kimberly-Clark completed its acquisition of Kenvue (spinoff of J&J's consumer health business). Q3 2026 net sales were $4.1B (down 0.4% reported; organic sales down 1.3% due to ~270bps China social media disruption headwind and North America inventory movements). Adjusted operating profit declined 0.9% YoY to $677M; adjusted EPS from continuing operations rose 17.2% to $1.70 (aided by lower interest expense and tax rate), but adjusted EPS attributable to KMB fell 6.6% to $1.70 due to discontinued operations. Company reaffirmed 2026 guidance: organic sales ~100bps below category growth (~1.7%); adjusted operating profit growth mid-single digits; adjusted EPS from continuing operations growth high single digits on constant-currency basis.
Why this rating

Kenvue acquisition materially transforms KMB's portfolio and size (estimated ~$13B+ incremental revenue). Significant integration execution risk, substantial debt incurrence ($1.3B+ proceeds noted), and near-term earnings headwinds from China disruption and pricing pressure. However, core business remains stable; dividend raised. Meaningful deal relative to $42.8B market cap, but integration success uncertain.

Price action (we called it neutral)
before filing · preread
$109.53 ▲ 0.82%
at our read · unknown
$108.64
+10 min · unknown
$110.06 ▲ 1.30%
+30 min · unknown
$110.57 ▲ 1.78%
+1 hr · unknown
$111.77 ▲ 2.88%
+4 hrs · unknown
$110.21 ▲ 1.45%

The stock had already moved -0.81% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ KMB · stock on Yahoo Finance ↗

See more from November 5, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.